To investigate the long-term effects and safety of new direct anti-viral agents (DAAs) in patients with hepatitis C virus (HCV)-related mixed cryoglobulinaemia (MC) without renal involvement.

Mazzaro, C., Dal Maso, L., Quartuccio, L., Ghersetti, M., Lenzi, M., Mauro, E., et al. (2018). Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 36 Suppl 111(2), 107-114.

Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study

Lenzi, Marco;
2018

Abstract

To investigate the long-term effects and safety of new direct anti-viral agents (DAAs) in patients with hepatitis C virus (HCV)-related mixed cryoglobulinaemia (MC) without renal involvement.
2018
Mazzaro, C., Dal Maso, L., Quartuccio, L., Ghersetti, M., Lenzi, M., Mauro, E., et al. (2018). Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 36 Suppl 111(2), 107-114.
Mazzaro, Cesare; Dal Maso, Luigino; Quartuccio, Luca; Ghersetti, Michela; Lenzi, Marco; Mauro, Endri; Bond, Milena; Casarin, Pietro; Gattei, Valter; C...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/674144
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 14
social impact